RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma
Not Applicable
Not yet recruiting
- Conditions
- Radical Antegrade Modular Pancreatosplenectomy
- Interventions
- Procedure: Standard retrograde pancreatosplenectomyProcedure: Radical antegrade modular pancreatosplenectomy
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 224
- Registration Number
- NCT04253847
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Unilateral GPi vs Unilateral STN DBS in the Same Patient With PD
Not Applicable
Completed
- Conditions
- Parkinson DiseaseGlobus Pallidus InternaDeep Brain StimulationSubthalamic Nucleus
- Interventions
- Procedure: DBS
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2021-03-04
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT04255719
- Locations
- 🇨🇳
Functional neurosurgery of Shanghai jiaotong university affiliated Ruijin hospital, Shanghai, Shanghai, China
A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.
Phase 2
- Conditions
- Breast CancerHER2-positive Breast CancerER-positive Breast Cancer
- Interventions
- First Posted Date
- 2020-01-22
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 37
- Registration Number
- NCT04236310
The Efficacy and Mechanism of DBS in VIC and NAcc for Refractory OCD
Not Applicable
- Conditions
- Deep Brain StimulationObsessive-Compulsive Disorder
- Interventions
- Device: DBS system
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04228744
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, China
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
Not Applicable
Recruiting
- Conditions
- Minimally Invasive SurgeryPancreatic Ductal Adenocarcinoma
- Interventions
- Procedure: robotic surgeryProcedure: open surgery
- First Posted Date
- 2019-12-26
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT04211948
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules
Not Applicable
Completed
- Conditions
- Lung Neoplasms
- Interventions
- Device: LungBrella marker implantation and VATS partial lobe resection
- First Posted Date
- 2019-12-26
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT04211051
- Locations
- 🇨🇳
RuijinhospitalRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer
Phase 2
Active, not recruiting
- Conditions
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Interventions
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 580
- Registration Number
- NCT04208347
- Locations
- 🇨🇳
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
🇨🇳Lanzhou University Second Hospital, Lanzhou, China
🇨🇳Affiliated Hospital of Hebei University, Baoding, China
SNS for Treatment of PD Gait Disorder
Not Applicable
- Conditions
- Gait Disorders, NeurologicParkinson Disease
- Interventions
- Device: Sacral Nerve Stimulation
- First Posted Date
- 2019-10-23
- Last Posted Date
- 2019-10-23
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT04137146
- Locations
- 🇨🇳
Functional neurosurgery of Shanghai jiaotong university affiliated Ruijin hospital, Shanghai, Shanghai, China
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
Not Applicable
Active, not recruiting
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Procedure: Standard LymphadenectomyProcedure: Extended Lymphadenectomy
- First Posted Date
- 2019-10-04
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04115527
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma
Phase 2
- Conditions
- Nasal Type Extranodal NK/T-Cell Lymphoma
- Interventions
- Drug: Anti-PD-1 monoclonal antibody
- First Posted Date
- 2019-09-20
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT04096690
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath